Bristol Myers moves to enforce transgenic mice award

US pharmaceuticals company Bristol Myers Squibb has asked a US court to enforce an AAA award it won against Switzerland’s Novartis over royalty payments due for the use of genetically modified laboratory mice.

Unlock unlimited access to all Global Arbitration Review content